Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Bindu

Bindu Akam, Andhra Pradesh IN

Patent application numberDescriptionPublished
20090075636METHOD AND SYSTEM FOR TRANSMITTING THE IDENTITY OF A USER IN A MOBILE TELECOMMUNICATIONS NETWORK - The invention consists of a method and a system arranged to transmit an identity of a user from a terminal to a database adapted to permanently store information of said user, in a mobile telecommunications network, comprising: inputting means adapted to allow said user to input said identity at said terminal, whereby said identity is modified on a permanent basis by said user; transmitting means adapted to transmit in the form of a message, said identity from said terminal to said database; storing means adapted upon reception of said message to store said identity at said database.03-19-2009

Bindu Chandna, Burlington, MA US

Patent application numberDescriptionPublished
20100054321Systems and Methods that Provide Frequency Domain Supplemental Training of the Time Domain Equalizer for DMT - Using a known or later developed time domain equalizer coefficient training algorithm, a least square solution for the time domain equalizer coefficients is taken at a starting point and iteratively improved on. In particular, the improvement is directed towards maximizing number of bits per frame loaded over the time domain equalizer coefficient choice. This can be accomplished by maximizing capacity directly rather than setting a goal to shorten the channel and hoping that the capacity will be maximized as a result.03-04-2010
20100290514Systems and Methods that Provide Frequency Domain Supplemental Training of the Time Domain Equalizer for DMT - Using a known or later developed time domain equalizer coefficient training algorithm, a least square solution for the time domain equalizer coefficients is taken at a starting point and iteratively improved on. In particular, the improvement is directed towards maximizing number of bits per frame loaded over the time domain equalizer coefficient choice. This can be accomplished by maximizing capacity directly rather than setting a goal to shorten the channel and hoping that the capacity will be maximized as a result.11-18-2010

Patent applications by Bindu Chandna, Burlington, MA US

Bindu Manojkumar, Maharashtra IN

Patent application numberDescriptionPublished
20100234468NOVEL PROCESS - The present invention relates to a process for the preparation of polymorphic forms of the R- and S-enantiomers of modafinil, R-(−)-2-benzhydrylsulfinylacetamide and S-(+)-2-benzhydrylsulfinylacetamide respectively.09-16-2010
20100234590PROCESS FOR THE PURIFICATION NE OF OLANZAPINE - The present invention relates to a novel process for the preparation of pharmaceutically pure olanzapine. The invention is also related to impurities obtained during the preparation of pharmaceutically pure olanzapine and methods for the detection of the impurities.09-16-2010
20100249162PROCESS FOR THE INTRODUCTION OF HYDROXYETHOXY SIDE CHAIN IN BOSENTAN - The present invention relates to an improved process for the preparation of bosentan. In particular it relates to a process for preparing bosentan substantially free from the dimer impurity of formula (II) and the 6-hydroxy impurity of formula (III). The invention also relates to a pharmaceutical composition comprising bosentan and its use in the treatment of endothelin-receptor mediated disorders.09-30-2010
20100261742NOVEL POLYMORPHIC FORMS - Novel polymorphic forms of bosentan and processes for their preparation are disclosed. Further, pharmaceutical compositions comprising said polymorphic forms and the use of said compositions in the treatment of patients suffering from endothelin receptor mediated disorders, for example, cardiovascular disorders such as hypertension, pulmonary hypertension, ischemia, vasospasm and angina pectoris are disclosed.10-14-2010
20100324139PROCESS TO PREGABALIN - The present invention relates to a novel method for the preparation of racemic pregabalin (1) or a single enantiomer thereof, (S)-(+)-3-(aminomethyl)-5-methyl-hexanoic acid (2).12-23-2010
20110028508NOVEL PROCESS FOR THE PREPARATION OF SCOPINE ESTERS - The present invention relates to novel processes for the preparation of scopine esters and their quaternary salts. In particular, the present invention relates to a process for the preparation of tiotropium bromide, pharmaceutical compositions comprising tiotropium bromide and the use of such compositions in the treatment of respiratory disorders.02-03-2011
20110039871PROCESS FOR PREPARING BOSENTAN - The present invention relates to a novel intermediate useful in the preparation of bosentan and to processes for the preparation of said intermediate and bosentan. The invention further relates to compositions comprising bosentan prepared according to the processes of the invention and their use in the treatment of endothelin-receptor mediated disorders.02-17-2011

Bindu Mnaojkumar, Maharashtra IN

Patent application numberDescriptionPublished
20090306170SYNTHESIS OF TEGASEROD OR A SALT THEREOF - The present invention relates to a novel process for the synthesis of 1-((5-methoxy-1H-indol-3-yl)methyleneamino)-3-pentyl-guanidine, commonly known as tegaserod, which is used as a gastroprokinetic, and salts thereof. The present invention also relates to tegaserod and salts thereof having an HPLC purity of about 95% or more. The present invention further relates to pharmaceutical compositions comprising tegaserod or a salt thereof, second medical uses of tegaserod or a salt thereof, and methods of treating or preventing irritable bowel syndrome using tegaserod or a salt thereof.12-10-2009

Bindu Rao, Laguna Nigel, CA US

Patent application numberDescriptionPublished
20110029607Configuring Consumption Of Service For Electronic Devices - One embodiment of a method for configuring consumption of service includes identifying a service to be consumed by a user, identifying a plurality of bearer technologies across which at least one electronic device can access the service, selecting one of the plurality of bearer technologies for use in configuring the at least one electronic device, and configuring the at least one electronic device for the service using one of a plurality of management frameworks according to the selected bearer technology.02-03-2011

Bindu Santhamma, San Antonio, TX US

Patent application numberDescriptionPublished
20100261896METHODS FOR THE PREPARATION OF DROSPIRENONE - Described herein are methods of making drospirenone. Also described are intermediate compounds that may be used to synthesis drospirenone.10-14-2010

Bindu Tejura, Cambridge, MA US

Patent application numberDescriptionPublished
20100286105METHODS OF TREATING HYPERANDROGENISM AND CONDITIONS ASSOCIATED THEREWITH BY ADMINISTERING A FATTY ACID ESTER OF AN ESTROGEN OR AN ESTROGEN DERIVATIVE - Compositions and methods for treating hyperandrogenism and conditions associated therewith, including polycystic ovary syndrome are disclosed. The invention is directed to methods for treating hyperandrogenism and conditions associated therewith, in a subject comprising administering a fatty acid ester of an estrogen or an estrogen derivative. Furthermore the invention is directed to compositions for treating hyperandrogenism and conditions associated with hyperandrogenism, including polycystic ovary syndrome, comprising a fatty acid ester of an estrogen or an estrogen derivative.11-11-2010

Bindu Tejura, New York, NY US

Patent application numberDescriptionPublished
20080261936METHODS OF REDUCING THE BODY WEIGHT OF A SUBJECT BY ADMINISTERING A FATTY ACID ESTER OF AN ESTROGEN OR ESTROGEN DERIVATIVE IN AN OIL AND COMPOSITIONS CONTAINING THE SAME - Compositions and methods for reducing the body weight of a subject are disclosed. The invention is directed to methods for reducing the body weight in a subject comprising administering therapeutically effective amounts of a fatty acid ester of an estrogen or estrogen derivative in an oil. Furthermore the invention is directed to compositions for reducing the body weight in a subject comprising administering therapeutically effective amounts of a fatty acid ester of an estrogen or estrogen derivative in an oil.10-23-2008